The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.

TCTMD spoke with Batchelor about how executive orders on DEI and federal funding are impacting the research ecosystem.

More Americans became sick from contaminated food last year, with the number of hospitalizations and deaths from foodborne ...

Avrum Z. Bluming, MD, an expert on hormone replacement therapy, debunks the menopause misconceptions that keep women from ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

(Reuters) -AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal ...

A device long used by adults to manage migraines was now available for children as young as eight years old, offering new ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

The U.S. Food and Drug Administration is warning retailers and restaurants not to sell certain oysters that could be ...